Search for: "BRISTOL-MYERS SQUIBB COMPANY" Results 81 - 100 of 350
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Dec 2019, 10:15 am by IPWatchdog
This week in Other Barks & Bites: the Inventor Rights Act is introduced into the House of Representatives; House overwhelmingly passes USMCA; major tech companies lobby the European Commission to address holdups in patent licensing; Cox Communications is hit with a billion-dollar verdict in a major copyright case; the USPTO issues a second extension to the effective date of its mandatory electronic trademark filing rule; the Copyright Office appoints Maria Strong as Acting Register of… [read post]
14 Jun 2018, 6:30 am by Jinks, Crow & Dickson, P.C.
Abilify lawsuits involve claims against the drug’s manufacturers, Otsuka Pharmaceutical Company and Bristol-Myers Squibb for negligence in creating a drug that was defectively designed and manufactured. [read post]
14 Jun 2018, 6:30 am by Jinks, Crow & Dickson, P.C.
Abilify lawsuits involve claims against the drug’s manufacturers, Otsuka Pharmaceutical Company and Bristol-Myers Squibb for negligence in creating a drug that was defectively designed and manufactured. [read post]
10 Sep 2008, 9:32 pm
Recall That Bristol-Myers Had Said Decline In Sales Was Reason For Its Decision To Stop Selling Tequin (Posted by Tom Lamb at DrugInjuryWatch.com) On September 2, 2008 the FDA issued a Notice entitled "Determination That TEQUIN (Gatifloxacin) Was Withdrawn From Sale for Reasons of Safety or Effectiveness"  which provides (and confirms) the real reason that Bristol-Myers Squibb Co. [read post]
22 Jun 2017, 11:23 am by Michael J. Mueller
Bristol-Myers Squibb (“BMS”) objected to the exercise of personal jurisdiction over it with respect to the nonresident plaintiffs’ claims. [read post]
26 Oct 2015, 8:05 am by SEClaw Staff
Two Grant Thornton Firms With Violating Auditor Independence RulesGrant Thornton India LLP and Australia-based Grant Thornton Audit Pty Limited have been charged with auditor independence violations that occurred when two Grant Thornton Mauritius partners served on the boards of Mauritius-based subsidiaries of companies that were Grant Thornton audit clients and performed non-audit services prohibited under the SEC’s auditor independence rules.New Jersey Fund Manager Charged With… [read post]
31 Jan 2015, 8:47 pm by Mark Summerfield
The issue of what, exactly, is ‘implicitly’ disclosed in a prior art reference arises in a decision of a full bench of the Federal Court issued on 23 January 2015 (Bristol-Myers Squibb Company v Apotex Pty Ltd [2015] FCAFC 2) in an appeal relating to a long-running dispute over the validity of a patent covering the antipsychotic drug aripiprazole. [read post]
3 Apr 2009, 8:31 am by VC
Case Study – 01 Let us take example of Bristol-Myer Squibb (BMS) patented drug Dasatinib for which Hetero Drugs filed an application with the DCGI for marketing approval of generic dossier of Dasatinib. [read post]
27 Apr 2008, 9:57 pm
  In March 2002, Sanofi-Synthelabo and Bristol-Myers Squibb sued Apotex for infringing the Orange Book-listed patent, U.S. [read post]
10 Oct 2017, 3:59 am by Broc Romanek
Tune in today for the webcast – “E&S Disclosures: The In-House Perspective” – to hear National Vision’s Jared Brandman, Davis Polk’s Ning Chiu, Bristol-Myers Squibb’s Kate Kelly, Apple’s Jung-Kyu McCann and Clorox’s Stephanie Tang discuss environmental & social disclosure issues – in both SEC filings & other types of filings. [read post]
13 Jul 2020, 8:49 am by Joy Waltemath
The court does not have personal jurisdiction over any opt-in servers who did not work in Pennsylvania, the employer contended, citing the Bristol-Myers Squibb Company v. [read post]
23 Feb 2009, 1:19 am
The commercials for Bristol-Myers Squibb's (BMS) new Rheumatoid Arthritis Drug, Orencia (c). [read post]